ImmunoGen, Inc.

UBS Group AG

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/9/2024

Shares

201,197

Value ($000)

5,965

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/9/2024	5,965	0.0%	201,197	12/31/2023
2023 Q3	11/9/2023	3,367	0.0%	212,180	9/30/2023
2023 Q2	8/11/2023	2,565	0.0%	135,931	6/30/2023
2023 Q1	5/12/2023	2,097	0.0%	546,102	3/31/2023
2022 Q4	2/8/2023	4,691	0.0%	945,688	12/31/2022
2022 Q3	11/10/2022	694	0.0%	145,191	9/30/2022
2022 Q2	8/10/2022	883	0.0%	196,187	6/30/2022
2022 Q1	5/16/2022	2,753	0.0%	578,502	3/31/2022
2021 Q4	2/14/2022	2,242	0.0%	302,097	12/31/2021
2021 Q3	11/15/2021	103	0.0%	18,125	9/30/2021
2021 Q2	8/13/2021	437	0.0%	66,352	6/30/2021
2021 Q1	5/12/2021	1,867	0.0%	230,543	3/31/2021
2020 Q4	2/11/2021	103	0.0%	16,020	12/31/2020
2020 Q3	11/12/2020	60	0.0%	16,572	9/30/2020
2020 Q2	7/31/2020	162	0.0%	35,243	6/30/2020
2020 Q1	5/1/2020	422	0.0%	123,615	3/31/2020
2019 Q4	2/14/2020	1,078	0.0%	211,302	12/31/2019